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Abstract 
 
High-resolution, non-destructive imaging with micro-computed tomography (CT) enables in 
situ monitoring of tissue engineered bone constructs. However, it remains controversial, if the 
locally imposed X-ray dose affects bone development and thus may influence the results. Here, 
we developed a model system for CT monitoring of tissue engineered bone-like constructs. We 
examined the in vitro effects of high-resolution CT imaging on the cellular level by using pre-
osteoblastic MC3T3-E1 cells embedded into three-dimensional (3D) collagen type I matrices. We 
found no significantly reduced cell survival 2 h after irradiation with a dose of 1.9 Gy. However, 
24 h post-irradiation, cell survival was significantly decreased by 15 % compared to non-
irradiated samples. The highest dose of 7.6 Gy decreased survival of the pre-osteoblastic MC3T3-
E1 cells by around 40 % at 2 d post-irradiation. No significant increase of Alkaline Phosphatase 
(ALP) activity at 2 d post-irradiation was found with a dose of 1.9 Gy. However ALP-activity 
was significantly decreased after 7 d. Using our model system, the results indicate that CT  
imaging with doses as low as 1.9 Gy, which is required to obtain a reasonable image quality, can 
induce irreparable damages on the cellular level.  
 
 
Keywords: Alkaline Phosphatase Activity (ALP); Cell survival; Collagen; MC3T3-E1 pre-
osteoblastic cells; Micro-computed tomography (CT); Tissue Engineering  
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Introduction 
The in vitro engineering of functional tissue constructs gained importance in the last decade 
as the shortage of organs and tissues for transplantation increased [21], but also for safety and 
efficacy testing of new therapeutics [8,12,15]. So far, quality testing of engineered tissue 
constructs relied on destructive techniques including reverse transcription polymerase chain 
reaction (RT-PCR) to analyze gene expression or histology to assess organization and integrity of 
the tissue. Thus, monitoring over time and functional optimization in response to assessed 
changes in tissue morphology and functionality was not possible with these techniques. Other 
methods, such as magnetic resonance imaging (MRI) or positron emission tomography (PET) do 
not provide sufficient spatial resolution [10,17].  
µCT was shown to be useful as a non-destructive method in imaging 3D bone 
microarchitecture at resolutions in the order of 10 μm in relatively short acquisition time (5-30 
min), and at low cost [2,3,19]. In recent studies, µCT was used to monitor the development of 3D 
in vitro engineered bone-like tissues [4,13,14], cartilage-like tissues [23], or skin-like layers [20] 
over time. However, a draw-back of obtaining high-quality µCT images may be the locally 
deposed radiation dose and its potential effect on cell survival, cell functionality and cell  
development [11].  
Several studies have examined the effects of ionizing radiation on bone cells in a two-
dimensional (2D) environment at doses up to 8 Gy [5,6,9]. While the proliferation of MC3T3-E1 
pre-osteoblastic cells and osteoblast-like cells from the rat calvarium was not affected by a 
radiation dose of 0.4 Gy, a dose of 4.0 Gy significantly decreased proliferation in all studies, in 
some cases significantly altered ALP activity, collagen production and vascular endothelial 
growth factor (VEGF) secretion as compared to non-irradiated control samples. However, 
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irradiation effects on 3D tissue engineered constructs, which mimic native 3D tissue and organ 
structures better than 2D environments [8,12], are not fully understood. Specifically, the critical 
dose, which can maximally be deposited onto the constructs without inducing cellular damages, 
is not clear. Since there is a big difference between a flat layer of cells and a complex 3D tissue 
[1] it is important to investigate the irradiation effect in 3D tissues. 
The goal of this study was to assess this maximum dose. We have developed a model 
system for μCT monitoring of 3D tissue engineered constructs, and to elucidate effects of the 
ionizing radiation applied by μCT imaging on the cellular level by using MC3T3-E1 pre-
osteoblastic cells embedded in 3D collagen type I matrices mimicking bone-like tissue [7,16]. We 
hypothesized that the locally deposed X-ray dose by high-resolution μCT imaging may cause 
alterations on the cellular level in a dose- and time-dependent manner. This may affect the 
development of engineered 3D tissue constructs for clinical applications, but also the results of 
pharmaceutical studies for testing new therapeutics.  
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Materials & Methods 
Dose measurement with thermo luminescent detectors 
The radiation dose occurring with typical settings for µCT scanning was measured with 
thermo luminescent detectors (TLD) made of lithium fluoride powder embedded in a glass tube 
of  12 mm length and 1.4 mm diameter (TLD-700, Harshaw/Filtrol, Solon, OH, USA). For the 
CT measurement, the TLD’s were placed in a cylindrical polymethyl methacrylate (PMMA) 
cylinder (inner diameter: 2 mm, outer diameter: 8 mm) to ensure corresponding radiation doses as 
applied to the cells embedded into the collagen matrix. The µCT (CT40, Scanco Medical AG, 
Brüttisellen, Switzerland) was operated at a peak voltage of 50 kV with an integration time of 
100 ms in all possible scanning modes. The three primary scanning modes provided by the 
microCT manufacturer were “standard resolution” mode (250 projections/180°, 1024 samples per 
projection), “medium resolution” mode (500 projections/180°, 1024 samples), and “high 
resolution” mode (1000 projections/180°, 2048 samples). In each mode, five different nominal 
resolutions were available namely 12, 16, 20, 30, and 36 µm for the standard and medium 
resolution mode, and 6, 8, 10, 15, and 18 µm for the high resolution mode. These nominal 
resolution values correspond to the settings that can be chosen to run the scans and do not 
represent the actual spatial resolution, which is typically lower. The best spatial resolution (10% 
MTF) at 6 µm voxel size is specified by the manufacturer to be 10 µm. After irradiation, the 
TLD’s were read out with a photo-multiplier using a standard heating protocol.  
For all cell experiments the medium resolution mode at 20 µm nominal resolution was used, 
but with a threefold increased integration time resulting in a calculated base dose of 1.9 Gy per 
measurement. To achieve the higher doses of 3.8, 5.7, and 7.6 Gy, the base measurement was 
repeated 2, 3, and 4 times, respectively. The total times for application of these radiation doses 
were 1.5 h, 3 h, 4.5 h and 6 h, respectively. To examine potential differences in image quality, a 
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bovine trabecular bone sample was scanned with µCT in four different modes: in standard 
resolution mode at 30 m and 16 m nominal resolution, as well as in high resolution mode at 15 
m and 8 m nominal resolution. 
 
Culture of pre-osteoblastic MC3T3-E1 cells 
A MC3T3-E1 subclone 24 (LGC Promochem Sarl, Molsheim Cedex, France) was cultured 
between passage 6-10 in alpha-modified minimum essential medium containing 10 % fetal 
bovine serum (FBS, both Invitrogen, Basel, Switzerland), 1 μg/mL bone morphogenic protein-2 
(BMP-2) produced as previously shown [22], and 25 mMol 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) (Sigma-Aldrich, Buchs, Switzerland). 
 
Preparation of 3D collagen matrices 
Collagen type I matrices (Vitrogen 100, Cohesion, Palo Alto, CA, USA) of 2 mg/mL were 
used. Matrix formation was initiated by raising the pH to physiological conditions (pH 7.4) by 
adding 0.1 M NaOH to the collagen solution. To ensure homogenous cell encapsulation, the 
matrices were pre-solidified at 37° C for 5 min prior to the addition of 500’000 cells/mL collagen 
I. Matrices with a volume of 30 L were then filled into sterilized (70% Ethanol, exposure to UV 
light) PMMA sample holders with a capacity of 35 L and incubated for 30 min at 37° C to 
solidify. The sample holders containing the 3D cell cultures were then kept in 1 mL medium in a 
well of a 24-well plate under standard cell culture conditions.  
 
Irradiation with CT 
A high-resolution micro-computed tomography system (CT40, Scanco Medical AG, 
Brüttisellen, Switzerland) was used to apply the ionizing radiation to the cells embedded in the 
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3D collagen type I matrices. The system was operated in all cell experiments at a peak voltage of 
50 kV with an integration time of 300 ms at a nominal resolution of 20 µm. The absolute dose 
delivered to the samples was assessed in an independent experiment using TLD’s. In all 
experiments, cultured MC3T3-E1 cells embedded in 3D collagen type I matrices were exposed to 
radiation 24 h after seeding into the collagen matrix. For cell survival experiments, cells were 
irradiated with doses of 1.9, 3.8, 5.7, and 7.6 Gy. For DNA and ALP assays, a dose of 1.9 Gy was 
applied. Control samples were placed inside the μCT, shielded with a lead cylinder against 
potential irradiation. Temperature effects on cell survival and ALP expression during a μCT run 
can thus be excluded. Survival experiments as well as ALP/DNA experiments were all compared 
with this μCT control.   
 
Cell survival after μCT irradiation 
Cell survival after μCT irradiation was determined with a Live/Dead cytotoxicity kit 
(Molecular Probes, Eugene, OR, USA). This assay was performed 2 h and 24 h post-irradiation 
(per dose, and per timepoint: nSamples   = 3;  nControl  = 9). The samples were washed in phosphate-
buffered saline (PBS, Sigma Aldrich, Basel, Switzerland) and stained for 45 min with 200 µL 
Live/Dead staining solution (4 M ethidium homodimer-1, 2 M calceinAM in PBS). The 
samples were then washed in PBS and fixed in 4 % glutaraldehyde. Epifluorescence images were 
taken at five randomly selected locations (area of 2 x 1 mm2) within the matrix by using a 
fluorescence microscope (Zeiss Axiovert 135, Feldbach, Switzerland) and the fluorescence for 
calceinAM was determined with an excitation wave length of 495 nm and an emission 
wavelength of 515 nm. For ethidium homodimer-1, an excitation wavelength of 495 nm and an 
emission wavelength of 635 nm were used, respectively. The number of surviving cells per total 
number of cells (live cells plus dead cells, between 30 and 100 cells in total, per location) was 
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determined by manual counting. The cell numbers of the irradiated samples were normalized to 
the non-irradiated control samples, which were placed into the μCT with lead shielding.  
 
ALP activity assay 
Each sample was homogenized in 300 μL lysis solution (0.2 % v/v Triton X-100 in 0.56 M 
2-amino-methyl -1-propanol pH 10.0). Total number of samples/controls per timepoint: nSamples   
= 10;  nControl  = 10. From each sample an aliquot was used to determine ALP-activity. Briefly, 
150 μL of the lysed cell suspension was mixed with 20 μL of P-nitrophenyl phosphate solution 
(74 mg/mL in 0.56 M 2-amino-methyl-1-propanol pH 10.0) and incubated at 37° C for 30 min. 
The reaction was stopped by addition of 85 μL 2 N NaOH. The ALP activity was then 
determined by measuring the absorbance at 405 nm with a spectrometer (Spectronic Genesys 
2PC, Thermo Fisher Scientific, Milford, MA, USA).  
 
DNA determination assay 
To determine the DNA content per gel, 30 µL of the lysed cell suspension was neutralized 
by addition of 270 µL TE-buffer (100 mM TrisHCl pH 7.6, 1 mM EDTA) and centrifuged for         
15 min at 14000 rpm. 270 µL of sample or DNA standard was then mixed with 270 µL Pico 
Green (Molecular Probes, Eugene, OR, USA) that was diluted 1:200 in TE-buffer. Total number 
of samples/controls per timepoint: nSamples   = 10;  nControl  = 10. Fluorescence was measured in 
triplicates using a spectrometer (Synergy HT, BioTek Instruments, Inc, Winooski, VT, USA) at 
520 nm (excitation wavelength: 480 nm).  
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Statistical analysis 
The cell survival experiments were performed at different doses, and are shown as mean 
values ± standard deviation Total number of samples: per dose and per timepoint: nSamples   = 3;  
nControl  = 9). Each sample point was normalized by its corresponding control sample. 
Comparative analysis was performed with a two-way ANOVA. To test for significant differences 
between the dose groups, a pair-wise t-test was applied with Holm correction for multiple testing, 
for both the 2 h and 24 h time groups. To examine significant differences between the 2 h and 24 
h time groups within a dose group, we used a Student’s t-test.  Significant differences were 
accepted for p < 0.05. 
The results of the DNA and ALP tests were statistically analyzed using a pair-wise 
Wilcoxon rank sum-test with Holm correction for multiple testing. Total number of 
samples/controls per timepoint: nSamples   = 10;  nControl  = 10. Differences between two data sets 
were considered statistically significant for p < 0.05. For all statistical analysis we used “R”, a 
language and environment for statistical computing (R Foundation for Statistical Computing, 
Vienna, Austria).   
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Results 
Dose measurement and image quality 
To investigate the relation between applied dose and image quality, a bovine trabecular 
bone sample was scanned with µCT applying the doses 0.150 Gy and 0.528 Gy in the Standard 
resolution mode, and 0.458 Gy and 1.980 Gy in the High resolution mode (Fig. 1A-C). Better 
image quality (higher resolution) resulted from higher applied doses (Fig. 1A). The grey-level 
images show a better quality by increasing the resolution from 30 to 8 µm, and with changing the 
imaging mode from Standard to High resolution. In addition, the binary images in High 
resolution mode were found to better display the “real” trabecular structure as compared to the 
binary images in the Standard resolution mode. However, the differences are relatively small and 
depending on the application a low resolution mode may yield reasonable results at an acceptable 
dose. We show, that the relation between dose and image quality, here represented as nominal 
resolution, can be modeled as a power law with exponents 1.74, 1.76, and 2.03, for the Standard, 
Medium and High resolution mode, respectively (Fig. 1B,C).  
 
Cell survival after μCT imaging is dose and time-dependent 
To examine the effects of high-resolution μCT imaging on a cellular-level, we first 
evaluated the survival rate 2 h and 24 h post-irradiation, with doses of 1.9, 3.8, 5.7 and 7.6 Gy, 
respectively, using custom-made PMMA sample holders. We found no significant increase in cell 
death for a dose of 1.9 Gy immediately (2 h) after irradiation as compared to the non-irradiated 
control group. However, 24 h post-irradiation, cell survival was significantly decreased by 15 % 
over the control group. Doses after exposure to 3.8 Gy and 5.7 Gy resulted in survival rates of 
around 80 %. While we did not find a significant decrease in cell survival after exposure to 3.8 
Gy between 2 h and 24 h post-irradiation, we demonstrate a significant decrease after exposure to 
 11
5.7 Gy by 15 %. The highest dose of 7.6 Gy decreased the survival rate of the cells by around 40 
% 24 h post-irradiation as compared to non-irradiated control samples. Nevertheless, no 
significant difference between 2 h and 24 h post-irradiation was observed for this highest dose.   
 
Time-dependent decrease of ALP-activity per cell  
To further investigate the cellular effects of high-resolution μCT imaging, we applied a 
dose of 1.9 Gy and analyzed ALP activity. When ALP-activity was normalized with the DNA 
content of the same sample, we found no significant increase in ALP-activity 2 d post-irradiation, 
but a significant decrease to about 60 % at 7 d (Fig. 3). 
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Discussion 
This is one of the first studies investigating the effect of ionizing radiation of high-
resolution µCT measurements on a cellular level by using a 3D tissue-like model system. Using 
our model system, the results indicate that CT imaging with doses as low as 1.9 Gy, which is 
required to obtain a reasonable image quality, may induce irreparable damages on the cellular 
level.   
The dose applied by a µCT measurement depends on the imaging mode and scanner 
settings, which are adapted to the features of interest. For instance, if bone volume density is of 
interest, a relatively low image quality may provide sufficiently good results. However, to 
capture alterations on the bone surface, a relatively good image quality with high resolution is 
required, which may need to expose the tissue to doses of 2 Gy or even higher. In such cases the 
applied dose is not negligible and may result in potential side effects on the cellular level as we 
demonstrated (Figure 2, 3). 
Our results indicate that the effects of ionizing radiation on survival of the pre-oesteoblastic 
MC3T3-E1 cells are different in our 3D model system with collagen type I matrices mimicking 
natural bone-like tissue as compared to 2D culture plates. We show considerably higher survival 
rates when similar doses are applied as previously reported for 2D studies (Figure 2A,B). For 
instance, it was demonstrated, that osteoblast-like cells from the calvarium of newborn rats 
survived only by 60 %, 35 % and less than 5 % on a 2D surface when 2, 4 and 6 Gy, respectively, 
were applied to the culture [5]. The reason for this difference is unclear. We speculate that the 3D 
organization of the cells mimicking a more natural tissue-like environment than a 2D culture may 
have a protective effect but also supports repair mechanisms more efficiently after irradiation 
damage. In addition, shielding effects of the PMMA sample holder may not be totally excluded.  
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Expression of ALP-activity is a relevant marker in the early differentiation process of 
MC3T3-E1 pre-osteoblastic cells towards mature osteoblasts as it is upregulated with proceeding 
maturation [18]. We show here a time-dependent decrease of ALP-activity after exposure to 
radiation (Fig. 3). While no significant alteration was found 2 d post-irradiation, the ALP-activity 
was significantly decreased at 7 d by around 60 %. We speculate that differentiation and 
maturation processes may be inhibited after irradiation. However, it is not clear, by which 
mechanisms the ALP-activity is influenced by irradiation. It may be as result of altered cytokine 
expression profiles, by the irradiation directly or by combined processes [6]. Other authors found 
inhibition of differentiation, when exposing mature osteoblasts in a 2D environment to 4 Gy 
doses.  In their study, ALP-activity normalized to the DNA-content was shown to be decreased 
by around 20 % after 3 d of irradiation, around 60 % after 6 d, and around 70 % after 9 d. 
However, a study using 3D scaffolds prepared from silk fibroin and human mesenchymal stem 
cells did not demonstrate alterations in ALP-activity after repeated high-resolution CT imaging 
over a period of 28 d [13]. The reasons for these controversial results on the ALP-activity may 
include different study designs including different cell types, radiation doses, the different times 
between the µCT imaging and the ALP-activity assays, which may allow DNA repair processes 
in some cases, as well as the different biophysical and biochemical properties of the 3D scaffolds 
used in the respective studies.  
The direct transfer of the results obtained in this study into in vivo experiments may not be 
possible, however the in vitro model system applied here, allows conclusions for in vitro tissue 
engineered constructs or bone chambers (i.e. critical dose). The critical dose for in vivo 
applications needs to be assessed with the respective in vivo models, specifically the effects on 
bone tissue growth, healing and turnover. Potential immune reactions, vascularization of the 
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tissue, and potential shielding effects of the surrounding tissue, may affect the critical dose in 
vivo. 
 
Conclusion 
We have established a model system allowing the monitoring of 3D tissue engineered 
constructs using CT imaging. Our results indicate significant impairments on the cellular level 
after imaging with high-resolution CT in a temporal and dose-dependent manner. Results from 
this study indicate that imaging with high-resolution CT with doses as low as 1.9 Gy, which is 
required to obtain a reasonable image quality, can yield irreparable damages on the cellular level.  
It is therefore recommended to use the lowest resolution necessary in monitoring studies of bone 
chambers and 3D tissue engineered bone-like constructs. Future studies may include other cells 
such as mesenchymal cells present in bone tissue, and/or different scaffolds, as well as 
longitudinal monitoring. Longitudinal animal studies may be performed to assess a critical in vivo 
dose to avoid potential damages on the cellular level.  
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Figure Legends 
Figure 1: Relation of CT image quality and applied dose. (A) µCT images of a bovine 
trabecular bone sample. Inserts show higher magnifications and the corresponding binary images, 
respectively. These scans were performed in four different modes; Standard resolution at 30 m 
and 16 m nominal resolution (voxel size), and High resolution at 15 m and 8 m nominal 
resolution. The nominal resolution corresponds to the scanner settings and not to the actual 
spatial resolution. (B) The relation between dose and image quality (here given as nominal 
resolution) can be modeled as a power law with exponents 1.74, 1.76, and 2.03, for Standard, 
Medium and High resolution mode. (C) Radiation dose in function of the imaging mode. For all 
cell experiments the Medium resolution mode at 20 µm nominal resolution was used, but with a 
threefold integration time resulting in a calculated base dose of 1.9 Gy per measurement. To 
achieve the higher doses of 3.8, 5.7, and 7.6 Gy, the base measurement was repeated 2, 3, and 4 
times, respectively. 
 
Figure 2: Survival of pre-osteoblastic MC3T3-E1 cells in 3D collagen matrices after CT 
imaging. (A) Representative image of pre-osteoblastic cells in 3D collagen matrices 24h post-
irradiation.  (B) Dose and time-dependent survival 2 h and 24 h after irradiation as assessed by 
quantifying Live/Dead cell staining. At a dose of 2 Gy, which is commonly applied for in vitro 
and in vivo imaging, the fraction of surviving cells 24h after irradiation is significantly lower 
than at 2h. The highest dose applied (8 Gy) still resulted in survival of > 60% both at 2h and 24h 
after irradiation. The survival rates at each dose were normalized by the survival rates of the 
control samples and are shown as mean values ± standard deviation (nSamples = 3, nControls =9; 
images were taken at five randomly selected/ representative locations within the matrix). 
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Significant differences were accepted for p < 0.05. * indicates significantly different data 
between 2 h and 24 h.  
 
Figure 3: Time-dependent decrease of ALP-activity after exposure to 1.9 Gy radiation dose. 
While no significant alteration in the 2 d post-irradiation group was found, the ALP-activity was 
significantly decreased by 60 % at 7 d post-irradiation. In these box plots, the box 
represents/contains 50 % of the data, and the whiskers show the data range excluding extreme 
values that are shown as single data points. Differences between two data sets were considered 
statistically significant for p < 0.05 and are indicated in the figure by a star. 
 
 
 
 
 
 
 
 



